They are usually the things youll be glad to have later
Abstract The unprecedented clinical success of glucagon-like peptide-1 (GLP-1) receptor agonists has transformed the therapeutic landscape for obesity, diabetes, and cardiometabolic disease, while simultaneously reshaping long-standing perceptions of peptide-based therapeutics as biologically compelling but pharmacologically impractical
There is no established pharmacokinetic or pharmacodynamic interaction between magnesium supplements and GLP-1 receptor agonists or tirzepatide
(2015) Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reaction protein, and other cardiovascular risk factors: a randomized controlled trial
Taking in extra B12 through injections or supplements when your levels are already normal will not provide additional benefits
(PubMed) Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A